Live feed03:00:00·2052dPRReleasevia QuantisnowWAYLIVRA▼® (volanesorsen), the First and Only Therapy for FCS, an Ultra-Rare and Life-Threatening Condition, to Be Available on the NHS in EnglandByQuantisnow·Wall Street's wire, on your screen.AKCA· Akcea Therapeutics, Inc.IONS· Ionis Pharmaceuticals Inc.Health CareFull content unavailable. See the original source below.Original source
